Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery presents new DNA-dependent protein kinase inhibitors

Oct. 28, 2021

TGF-beta receptor type-1 inhibitors discovered at Theravance Biopharma

Oct. 28, 2021

Vertex Pharmaceuticals identifies new SERPINA1 polymerization inhibitors

Oct. 28, 2021

CXCR4-CXCL12 signaling axis as therapeutic target for Lewy body dementia

Oct. 28, 2021

New nanoformulation provides a promising candidate for long-acting dosing of tenofovir

Oct. 28, 2021

PDGFRA overexpression in prenatal OPCs results in CNS hypomyelination

Oct. 28, 2021

New BBB-crossing FMR1-based AAVphp constructs for treatment of Fragile X syndrome

Oct. 28, 2021

Insight into CD200R signaling has implications for treating systemic lupus erythematosus

Oct. 28, 2021

RFN-ALFQ nanoparticle vaccine elicits immunity against SARS-CoV-2 in macaques

Oct. 27, 2021

mLB-001 GeneRide vector restores hepatocyte function in MMA mice

Oct. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...